A Cross-Border Biorisk Toolkit for Healthcare Professionals

Pierre Vandenberghe, Jessica S. Hayes, Maire A. Connolly and Jean-Luc Gala ()
Additional contact information
Pierre Vandenberghe: Centre for Applied Molecular Technologies (CTMA), Institute for Clinical and Experimental Research (IREC), Université Catholique de Louvain, Tour Claude Bernard, Avenue Hippocrate, 54–55, bte B1.54.01, 1200 Bruxelles, Belgium
Jessica S. Hayes: School of Health Sciences, College of Medicine, Nursing and Health Sciences, University of Galway, H91 TK33 Galway, Ireland
Maire A. Connolly: School of Health Sciences, College of Medicine, Nursing and Health Sciences, University of Galway, H91 TK33 Galway, Ireland
Jean-Luc Gala: Centre for Applied Molecular Technologies (CTMA), Institute for Clinical and Experimental Research (IREC), Université Catholique de Louvain, Tour Claude Bernard, Avenue Hippocrate, 54–55, bte B1.54.01, 1200 Bruxelles, Belgium

IJERPH, 2024, vol. 21, issue 9, 1-9

Abstract: The COVID-19 pandemic posed significant challenges to public health, exposing first responders to high biosafety risks during medical assistance and containment efforts. The PANDEM-2 study aimed to address these critical biosafety issues by emphasising the importance of frequently updated, harmonised guidelines. This study reviewed scientific publications, lessons learned, and real-world experiences from the COVID-19 pandemic to identify biorisk gaps in three critical areas: (i) patient transportation and management, (ii) sample handling and testing, and (iii) data management and communication by laboratory staff. At the onset of the pandemic, first responders faced several challenges, including the rapid expansion of emergency medical services, conversion of non-medical structures, increased internal and cross-border transport of infected patients, frequent changes in biosafety protocols, and a shortage of personal protective equipment. In response, this study developed a versatile and easily adaptable toolkit, including biosafety guidance and recommendations linked to updated national and international online repositories. It establishes the groundwork for a minimum standard that can be tailored to various pandemic response scenarios, using monkeypox as a fictive test case. The toolkit enables rapid access to updated information via QR codes and mobile devices, improving biorisk response by providing an adaptable and standardised approach for caregivers involved in national and cross-border responses.

Keywords: biohazard; biothreat; biosafety; monkeypox; COVID-19; pandemic; cross-border response; caregivers; first responders; mobile laboratory; guidelines (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2024
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/21/9/1261/pdf (application/pdf)
https://www.mdpi.com/1660-4601/21/9/1261/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:21:y:2024:i:9:p:1261-:d:1483927

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().